Patents invented by our scientists

No.	Publication Nr.	Title
1	WO2017135901	Heterocyclic compounds, methods of synthesis and uses thereof Examples: xlsx
2	EP3194399 US2017260187	New agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders
3	WO2017153789	Benzo[b]thiophene derivatives and their use for the inhibition of fibroblast growth factor receptor kinases (FGFRs) for the use of neo- and hyperplasia therapies Examples: xlsx
4	US20160113989	Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
5	WO2016042349	New agents for treating neurogenic inflammation and neuropathic hyperalgesia related disorders Examples: xlsx
6	WO2016041972 EP3194366 US2017240522	Benzothiophene, benzyloxybenzylidene and indoline derivatives useful for the treatment of tuberculosis Examples: xlsx
7	WO2016131789	Benzopyrrolidone derivatives possessing antiviral and anticancer properties
8	WO2014031937 CA2882733 EP2887943 MX2015002270 JP2015526479 US20140057911 EA201590417	Novel 4,6-disubstituted aminopyrimidine derivatives
9	WO2011077171 US9040529 EP2516405 DK2516405 ES2558132 JP5857211	4-Phenylamino-pyrimidine derivatives having protein kinase inhibitor activity Examples: xlsx
10	WO2015019121 US2016194291 CA2920754 EP3030550 JP2016529250	Styryl quinazoline derivatives as pharmaceutically active agents Examples: xlsx
11	WO2015022437 EP2837626	Indolinone derivatives as GRK5 modulators
12	WO2011045084 US9169241 CN102574804 EP2462117 HK1171017 US8685971 AU2010306003	Quinolinyloxyphenylsulfonamides
13	WO2014106762 US20150368209 EP2941428	4-Pyrimidinylamino-benzenesulfonamide derivatives and their use for the inhibition of polo-like kinase 1 (PLK1) for the treatment of cancer and their use for the treatment of bacterial infections Examples: xlsx
14	WO2014106763	Pyridopyrazines as anticancer agents Examples: xlsx
15	WO2011077171 DK2516405 EP2516405 ES2558132 US9040529 JP2013515047	4-Phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
16	WO2009127417 AU2009237938 CA2718538 CN102131783 EP2262772 IL208103 JP5746015 KR101325237 MX2010011224 RU2010146474 US9206130 ES2391373	Quinoline derivatives as axl kinase inhibitors
17	WO2012018370 EP2600721 US20120164132	Anticancer and immunomodulating molecules and fractions containing said molecules, and process for preparing said fractions and said molecules from fermented vegetal material, and their uses
18	WO2009104026 US20110015214 EP2257554	Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use Examples: xlsx
19	WO2010100515 US20110318409 EP2403513	Fractions of wheat germ ferment
20	WO2009104027	Therapeutic application of triciclic aromatic and saturated benzo(4,5)thieno-(2,3-d)pyrimidine derivates, as well as their therapeutically acceptable salts
21	WO2006021458 US20080187575 CA2578122 EP1786781 JP2008510766	Pyrimidine Derivatives
22	WO2007060028 CA2593718 EP1833832 US20080207677	Napthyridine Compounds As Rock Inhibitors
23	WO2005105804 US20080214583 CA2564277 AT462706 AU2005238287 CN1972946 EP1756110 HU0400891 JP2007534737 KR20070047737 RU2006141393	7h-Pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for production the active agent
24	WO2005023818 AU2004270394 CA2572750 EP1670804 US20070275962	Heterobicyclic Compounds as Pharmaceutically Active Agents Examples: xlsx
25	WO0156553 AT308982 AU4057801 EP1255541 ES2250363 US2003203969 DE60114772	Pharmaceutically active aromatic guanylhydrazones
26	WO2006089874	Benzo[2,3]azepino[4,5-b]indol-6-ones
27	US20040171603	Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor
28	WO02094796 AU2002312927	Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases Examples: xlsx
29	WO0220527 AU8613101 HU0003554	Soluble compounds for the inhibition of multidrug resistance and pharmaceutical compositions thereof
30	US6331555	Treatment of platelet derived growth factor related disorders such as cancers
31	HU226567	Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica
32	AT307145	Use of phenylhydrazone derivatives as antinflammatory or analgetic agents
33	CA2269995	Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica
34	EP0952159 DK0952159 DE69927735 ES2251803	Use of phenylhydrazone derivatives as antinflammatory or analgetic agents
35	JP2000001439 KR19990083438	Pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects
36	US6689813	Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica
37	HU214061	Process for producing phenylamino-acetly-hydrazide derivatives and pharmaceutical compositions containing the said compounds with tumor growth and enzyme-activity inhibiting effect
38	WO9519169 AT192925 AU690958 CA2180658 CN1065744 DE69517054 DK0804191 EP0804191 GR3034215 IL112277 PT804191 US5990141 ES2149966	Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor
39	HU209498	Process for producing 1,4-diazepino/3,4-b/quinasoline-3,7-dione derivatives and pharmaceutically acceptable salts thereof
40	WO9316064 AU3573893	Coumarin derivatives and their analogues inhibiting cell proliferation and tumour growth, pharmaceutical compositions containing them and process for preparing same
41	HUT63843	Process for producing new kumarin derivatives and their analogs inhibiting mammal cell proliferation and tumour growth, as well as pharmaceutical comkpositions comprising such compounds
42	HU208975	Process for producing imidazo/5,1-b/ quinazolin-9-one derivatives and pharmaceutically acceptable salts thereof, as well as thrombocyta aggregation inhibiting pharmaceutical compositions comprising such active ingredients
43	WO2014180544 EP2801573	Hydantoine derivatives as CD38 inhibitors